0001628280-20-017775.txt : 20201228
0001628280-20-017775.hdr.sgml : 20201228
20201228162738
ACCESSION NUMBER: 0001628280-20-017775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201223
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ragan Paula
CENTRAL INDEX KEY: 0001769914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 201418627
MAIL ADDRESS:
STREET 1: C/O X4 PHARMACEUTICALS, INC.
STREET 2: 955 MASSACHUSETTS AVE., 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_160919084166091.xml
FORM 4
X0306
4
2020-12-23
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001769914
Ragan Paula
C/O X4 PHARMACEUTICALS, INC.
61 NORTH BEACON STREET, 4TH FLOOR
BOSTON
MA
02134
1
1
0
0
President and CEO
Common Stock
2020-12-23
4
S
0
4800
7
D
280123
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
Of the shares of common stock reported, 101,714 shares represent unvested restricted stock units.
/s/ Derek M. Meisner, attorney-in-fact
2020-12-28